Ville Wallenius

Nordea Investment Management AB (NIM) is the Swedish investment management subsidiary of Nordea Asset Management Holding AB, itself a subsidiary of Nordea Bank ABp (HEL: NDA-FI, ADR: NRBAY) in Finland. Founded in 1954 as Merita Nordbanken Investment Management, the firm became Nordea Investment Management AB in 2001 when the Nordea name, an abbreviation of Nordic ideas, replaced Unibank, Nordbanken, Merita and Christiania Bank in a joint renaming operation. Headquartered in Stockholm, NIM manages a range of Swedish funds including pension funds, hedge funds, Luxembourg-domiciled SICAVs and funds registered in other Nordic countries for institutional clients.

Alfred Berg Asset Management AB (ABAM) is the Swedish asset management subsidiary of Alfred Berg Asset Management AB, ultimately held by BNP Paribas SA (XP: BNP, ADR: BNPQY) in France. The firm is based in Stockholm and manages assets for investment funds, charities, financial institutions, pension funds and individual investors. In combination with BNP Paribas Investment Partners products and services, they offer solutions across asset classes and investment styles and are the sole distributor of BNP Paribas Investment Partners investment products and services in the Nordic region.

Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.

MetCon Medicin AB develops and manufactures pharmaceutical products. Its products are used for oral administration and stabilizing blood sugar levels. The company's products are used for the treatment of diabetes and other metabolic diseases. MetCon Medicin was founded by Dr. Ulf Smith and Dr. Mats Lake in 1999 and is headquartered in Lidingo, Sweden.

The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson.

OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.

Lamera AB develops ultra-light metal composites. It engages in developing, producing, and marketing light stainless steel for energy absorption systems. The firm builds on Hybrix composite technology, which is a ultra light, thin, and formable metal sandwich material. The company was founded by Anders Samuel Axelsson and Mattias Grufberg on December 23, 2004 and is headquartered in Vastra Frolunda, Sweden.

Aluwave AB provides electronics cooling technology. The firm offers Alunat, a ceramic based metal core printed circuit board for the cooling of electronic assemblies. It serves automotive, architectural, design, decoration, sport, utility, and work lighting industries. The company was founded by Carl Jonas Stålhandske in 2005 and is headquartered in Molndal, Sweden.

Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden.

Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom.

Almi Invest AB (Almi) is a Venture Capital subsidiary of ALMI Företagspartner AB, founded in 2009. The firm is headquartered in Stockholm, Sweden.

Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden.

Inkubatorn i Borås AB provides business support to start-up companies. It provides an incubator program for start-up companies, and focuses on individual tutoring and assistance in aspects, such as financial, technical, and commercial networks. The firm finances companies in the early development stages and invests in spin-offs, projects, and researches at universities and research institutes. The company was founded on September 14, 2005 and is headquartered in Boras, Sweden.

Baricol Bariatrics AB develops, produces, and sells customized products and services for people who have undergone obesity surgery. The firm offers vitamins and minerals. Its customer include medical experts such as doctors and dieticians and people with long experience in the pharmaceutical industry. The company is headquartered in Gothenburg, Sweden.

Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy.

Busulipo AB is a Swedish company that manufactures and wholesales pharmaceutical and medical technology products. The private company is based in Stockholm, Sweden.

Mindforce Game Lab AB creates games for people with medical conditions, called Playtients™, to help them develop healthy habits. The games are designed to act as companions on the journey to better health and are created by bringing together leading life scientists and top game designers. The CEO of the Swedish company is Anders Rabbe.